Heterogeneous Expression and Activity of Endothelial and Inducible Nitric Oxide Synthases in End-Stage Human Heart Failure
- 14 July 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (2) , 132-139
- https://doi.org/10.1161/01.cir.98.2.132
Abstract
Background—Recent reports have suggested that excessive amounts of endogenous NO may contribute to the myocardial dysfunction and injury in heart failure. In the present report, we investigate the cellular expression and activity of endothelial (eNOS) and inducible (iNOS) NO synthase in failing human hearts with special reference to the underlying lesion and drug therapy. Methods and Results—Myocardial tissues were obtained from 28 failing human hearts with various pathogeneses and 4 nonfailing hearts as controls. Only weak or focal expression of both eNOS and iNOS was seen in ventricles of nonfailing hearts. In failing hearts, immunoreactivity and hybridization signals for eNOS were increased only in cardiac myocytes of subendocardial areas. Signals for iNOS in cardiac myocytes were consistently seen in heart failure of various pathogeneses and were apparent in both infarcted and noninfarcted regions of ischemic cardiomyopathy. Apparent signals for iNOS were also seen in infiltrating macrophages in infarcted regions of ischemic cardiomyopathy, myocarditis, and septic hearts. The expression of eNOS but not iNOS in the myocytes was intimately associated with β-adrenergic therapy before the operation, being more abundant in patients on β-blockers compared with diminished presence in patients on β-agonists. In contrast to immunohistochemical data, iNOS activity was more variable than constitutive NOS activity and correlated significantly with the density of infiltrating macrophages. Conclusions—These results suggest that whereas increased eNOS and/or iNOS expression in failing cardiac myocytes may in general contribute to myocardial dysfunction, myocyte injury or death associated with inflammatory lesions may be caused in part by abundant iNOS expression within infiltrating macrophages rather than cardiac myocytes.Keywords
This publication has 35 references indexed in Scilit:
- Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.Journal of Clinical Investigation, 1996
- Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavengerFEBS Letters, 1996
- Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.Heart, 1995
- Role of nitric oxide in the regulation of myocardial functionProgress in Cardiovascular Diseases, 1995
- Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarctionCardiovascular Research, 1995
- Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarctionCardiovascular Research, 1995
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy.Heart, 1994
- cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardiumCardiovascular Research, 1994
- Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension, 1994
- Basal and Isoprenaline-Stimulated cAMP Content in Failing Versus Nonfailing Human Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1989